<Editors' Choice> Prevalence of acute coronary syndrome during the pandemic of COVID-19 in the Tokai Region of Japan

Nagoya J Med Sci. 2021 Nov;83(4):697-703. doi: 10.18999/nagjms.83.4.697.

Abstract

The outbreak of coronavirus disease 19 (COVID-19) has had a great impact on medical care. During the COVID-19 pandemic, the rate of hospital admissions has been lower and the rate of in-hospital mortality has been higher in patients with acute coronary syndrome (ACS) in Western countries. However, in Japan, it is unknown whether the COVID-19 pandemic has affected the incidence of ACS. In the study, eleven hospitals in the Tokai region participated. Among enrolled hospital, we compared the incidence of ACS during the COVID-19 pandemic (April and May, 2020) with that in equivalent months in the preceding year as the control. During the study period; April and May 2020, 248 patients with ACS were admitted. Compared to April and May 2019, a decline of 8.1% [95% confidence interval (CI) 5.2-12.1; P = 0.33] in admissions for ACS was observed between April and May 2020. There was no significant difference in the strategy for revascularization and in-hospital deaths between 2019 and 2020. In conclusion, the rate of admission for ACS slightly decreased during the COVID-19 pandemic, compared to the same months in the preceding year. Moreover, degeneration of therapeutic procedures for ACS did not occur.

Keywords: COVID-19; acute coronary syndrome.

MeSH terms

  • Acute Coronary Syndrome / epidemiology*
  • COVID-19* / epidemiology
  • Humans
  • Japan / epidemiology
  • Pandemics
  • Prevalence
  • SARS-CoV-2